Australian Market Community

Karoon Energy Ltd – Fundamental Analysis Company Overview Karoon Energy Ltd is an ASX-listed international oil and gas exploration and production company with assets in: Brazil : Baúna Project (100% interest) USA : Who Dat, Dome Patrol, Abilene (various interests) Australia : Exploration assets Financial Performance 2024 Full-Year Highlights Revenue : US$776.5 million (+14% YoY) Underlying NPAT : US$214.0 million (+3% YoY) Statutory NPAT : US$127.5 million (↓39% YoY due to non-cash tax adjustments and exploration write-offs) Operating Cash Flow : US$434.6 million Free Cash Flow : US$176.6 million Net Debt : US$8.8 million (↓from US$103.7 million in 2023) Capital Returns : US$85.7 million (dividends + buybacks) Q2 2025 Performance Production (NRI) : 2.94 MMboe (↑25% QoQ) Sales Revenue : US$159.7 million (↑7% QoQ) Capex : US$102.9 million (includes Baúna FPSO acquisition) Net Debt : US$237.9 million (↑due to FPSO acquisition and buybacks) ⚙️ Operational Performance Baúna Project (Brazil) 2024 Production : 7.5 MMbbl FPSO Efficiency : 84.5% in 2024; targeted 88–92% in 2025 FPSO Acquisition : Completed April 2025; expected to reduce opex by US$4–6/bbl from 2026 SPS-92 ESP Issue : Temporary production drop; intervention planned for Q2 2026 Who Dat (USA) 2024 Production : 2.9 MMboe (NRI) 2025 Guidance : 2.3–2.8 MMboe Development : Sidetrack drilling and tieback studies underway; FID for East/South expected by early 2026 ️ Reserves & Resources 2P Reserves (2024) : 67.9 MMboe (↓from 77.5 MMboe due to production) 2C Contingent Resources : 121.4 MMboe (↑17% YoY) Includes Neon (Brazil) and Who Dat East/South (USA) Sustainability & ESG Carbon Neutral (Scope 1 & 2) : Achieved since FY21 Net Zero Target : By 2050 or sooner Social Projects : 21 planned for 2025; aligned with UN SDGs 2025 Guidance (as of August 2025) MetricGuidance Total Production9.7–10.5 MMboeUnit Production Cost (NWI)US$12.5–17.5/boeCapexUS$99–117 millionFinance CostsUS$50–60 millionPetrobras PaymentUS$88 million Investment Considerations ✅ Strengths Diversified production base (Brazil + USA) Strong cash generation and liquidity Strategic FPSO acquisition to improve efficiency Mature development pipeline (Neon, Who Dat East/South) Active capital return policy (dividends + buybacks) ⚠️ Risks Operational reliability issues (e.g., ESP failure at Baúna) High capex and net debt increase in 2025 Commodity price volatility Regulatory and environmental risks in Brazil and USA Conclusion Karoon Energy is fundamentally strong with solid financials, a diversified asset base, and a clear strategy for growth and shareholder returns. However, operational execution and commodity price stability will be key to sustaining performance.

GQG Partners is a funds management business that has recorded strong earnings growth over the past year, with EPS rising from US$0.095 to US$0.14. Since 2023 it has grown its funds under management from US$106 billion to US$143 billion, while return on equity sits near 80 per cent.

Pro Medicus (ASX: PME) is an Australian company that develops medical imaging software under its Visage product range. Leading medical institutions including NYU Langone, UCSF, and Mass General Brigham have publicly or semi-publicly praised the platform—often via PME-issued press releases or interviews.

Hipages appears to be at a significant turning point, showing strong signs of operational and financial health after a period of strategic change. The key takeaway from the FY25 results is the successful execution of its transition from a simple marketplace to a more integrated Software-as-a-Service (SaaS) platform, which is now yielding positive results.

Aurizon’s decade-long medians sit at –2.3 % revenue/share growth, 11.1 % net margin and a 17× P/E. Looking five years out, scenarios span 0–4 % top-line CAGR, 8–12 % margins and 9–14× multiples, hinging on Bulk-freight expansion, tariff indexation, cost inflation and ESG-driven market sentiment.

Forecasts for Growth, Future Revenue, Net Profit, and Key Metrics Forecasting LGP’s future performance involves assumptions based on FY2024 trends, market conditions, and strategic plans. Below are speculative projections for key metrics: Revenue Growth: FY2024 Baseline: $25.6 million, up 29% from $19.9 million in FY2023.

Pantoro Ltd is a mid-tier producer in Australia. They are producing around 100,000 oz (Norseman).

CSL Limited: Fair Value Assessment Amidst Evolving US Tariff Scenarios Executive Summary This report provides an assessment of the fair value of CSL Limited (CSL) under various potential United States (US) tariff scenarios. CSL, a global biotechnology leader with significant operations in plasma therapies (CSL Behring), influenza vaccines (CSL Seqirus), and iron/nephrology treatments (CSL Vifor), faces potential impacts from evolving US trade policies.

--- [Narrative update per Investor announcement 24-Mar-2025] --- The analysis below was written ahead of Opthea’s Phase 3 results. As stated, the thesis was highly dependent on trial success.